2023
Catheter Ablation for Ventricular Tachycardia After MI: A Reconstructed Individual Patient Data Meta-analysis of Randomised Controlled Trials
Reddy R, Howard J, Ahmad Y, Shun-Shin M, Simader F, Miyazawa A, Saleh K, Naraen A, Samways J, Katritsis G, Mohal J, Kaza N, Porter B, Keene D, Linton N, Francis D, Whinnett Z, Luther V, Kanagaratnam P, Arnold A. Catheter Ablation for Ventricular Tachycardia After MI: A Reconstructed Individual Patient Data Meta-analysis of Randomised Controlled Trials. Arrhythmia & Electrophysiology Review 2023, 12: e26. PMID: 38124803, PMCID: PMC10731517, DOI: 10.15420/aer.2023.07.Peer-Reviewed Original ResearchCatheter ablationMedical therapyIndividual patient dataCause mortalityPrior MIVT recurrenceDefibrillator shocksIndividual Patient Data Meta-AnalysisVentricular tachycardia catheter ablationReconstructed individual patient dataPrespecified primary endpointPrespecified secondary endpointPatient dataPrespecified subgroup analysisProportion of patientsRandomised Controlled TrialsIndividual patient assessmentData Meta-AnalysisCause hospitalisationPrimary endpointSecondary endpointsPrognostic impactControlled TrialsPatient assessmentSubgroup analysisCatheter ablation for ventricular tachycardia after myocardial infarction: meta-analysis of randomised controlled trials
Reddy R, Howard J, Ahmad Y, Shun-Shin M, Simader F, Miyazawa A, Saleh K, Samways J, Keene D, Linton N, Francis D, Whinnett Z, Luther V, Kanagaratnam P, Arnold A. Catheter ablation for ventricular tachycardia after myocardial infarction: meta-analysis of randomised controlled trials. European Heart Journal 2023, 44: ehad655.392. DOI: 10.1093/eurheartj/ehad655.392.Peer-Reviewed Original ResearchIndividual patient dataReconstructed individual patient dataPrior myocardial infarctionCatheter ablationMedical therapyMyocardial infarctionCause mortalityVT recurrenceDefibrillator shocksVentricular tachycardiaPatient dataCox proportional hazards regression modelPost-infarct ventricular tachycardiaPre-specified primary endpointPre-specified secondary endpointsVentricular tachycardia catheter ablationProportional hazards regression modelsResults Eight trialsProportion of patientsKaplan-Meier curvesHazards regression modelsCause hospitalisationPrimary endpointSecondary endpointsPrognostic impactCurrent Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review
Chuy K, Velazquez E, Lansky A, Jamil Y, Ahmad Y. Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 101197. DOI: 10.1016/j.jscai.2023.101197.Peer-Reviewed Original ResearchIschemic systolic heart failureSystolic heart failurePercutaneous coronary interventionHeart failureMedical therapyCoronary revascularizationBenefits of PCITrials of PCILeft ventricular systolic dysfunctionPrevalence of HFBenefit of CABGContemporary medical therapyIschemic ventricular dysfunctionCoronary artery bypassVentricular systolic dysfunctionCoronary artery diseaseIschemic heart diseaseAcute cardiac careComparative clinical effectivenessUnmet clinical needRecent revascularizationArtery bypassSystolic dysfunctionVentricular dysfunctionCoronary intervention
2022
Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials
Simader FA, Howard JP, Ahmad Y, Saleh K, Naraen A, Samways JW, Mohal J, Reddy RK, Kaza N, Keene D, Shun-Shin MJ, Francis DP, Whinnett ZI, Arnold AD. Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials. EP Europace 2022, 25: 341-350. PMID: 36305545, PMCID: PMC9934993, DOI: 10.1093/europace/euac173.Peer-Reviewed Original ResearchConceptsHeart failure hospitalizationCatheter ablationHeart failureMedical therapyFailure hospitalizationAtrial fibrillationCardiovascular outcomesPrimary analysisPre-specified primary endpointAtrial fibrillation catheter ablationCause mortalityPrimary endpointSecondary endpointsLower riskPatientsTherapyHospitalizationFibrillationTrialsMortalityLow heterogeneityAblationEndpointOutcomesFailureMechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trials.
Rajkumar CA, Ganesananthan S, Ahmad Y, Seligman H, Thornton GD, Foley M, Nowbar AN, Howard JP, Francis DP, Keeble TR, Grunwald IQ, Al-Lamee RK, Malik I, Shun-Shin MJ. Mechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trials. EuroIntervention 2022, 17: e1425-e1434. PMID: 34503942, PMCID: PMC9896406, DOI: 10.4244/eij-d-21-00343.Peer-Reviewed Original ResearchConceptsSymptomatic intracranial hemorrhageAcute ischemic strokeModified Rankin ScaleIschemic strokeCause mortalityMechanical thrombectomyAspiration catheterIntracranial hemorrhageRetrievable stentsAnterior circulation ischemic strokeLong-term neurological outcomeAcute anterior circulation strokeTrial of thrombectomyAnterior circulation strokeStandard of careIntravenous thrombolysisNeurological outcomeSecondary endpointsPrimary endpointSubsequent disabilityMRS scoreRankin ScaleMedical therapyThrombectomyTreatment strategiesPCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes
Ahmad Y, Petrie M, Jolicoeur E, Madhavan M, Velazquez E, Moses J, Lansky A, Stone G. PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100020. DOI: 10.1016/j.jscai.2022.100020.Peer-Reviewed Original ResearchPercutaneous coronary interventionLeft ventricular systolic dysfunctionCoronary artery diseaseHeart failureComplete revascularizationMedical therapyClinical outcomesClinical trialsCoronary artery bypassVentricular systolic dysfunctionClinical trial evidenceHigh operative riskHigh-risk patientsMajor cardiac surgeryExtent of revascularizationMinority of patientsFuture clinical trialsArtery bypassCause mortalityPeriprocedural complicationsSystolic dysfunctionCoronary interventionOperative riskArtery diseaseCardiac surgery
2018
Reply to: Assessing the quality of evidence supporting patent foramen ovale closure over medical therapy after cryptogenic stroke
Ahmad Y, Howard J, Arnold A, Shun-Shin M, Cook C, Francis D, Sen S. Reply to: Assessing the quality of evidence supporting patent foramen ovale closure over medical therapy after cryptogenic stroke. European Heart Journal 2018, 39: 3620-3620. PMID: 30137277, DOI: 10.1093/eurheartj/ehy498.Peer-Reviewed Original ResearchP716PFO closure is superior to medical therapy for cryptogenic stroke: a meta-analysis of randomised controlled trials
Ahmad Y, Howard J, Arnold A, Shun-Shin M, Cook C, Petraco R, Sutaria N, Malik I, Mayet J, Francis D, Sen S. P716PFO closure is superior to medical therapy for cryptogenic stroke: a meta-analysis of randomised controlled trials. European Heart Journal 2018, 39: ehy564.p716. DOI: 10.1093/eurheartj/ehy564.p716.Peer-Reviewed Original Research2 PFO closure is superior to medical therapy for cryptogenic stroke: a meta-analysis of randomised controlled trials
Ahmad Y, Howard J, Arnold A, Shun-Shin M, Cook C, Malik I, Mayet J, Francis D, Sen S. 2 PFO closure is superior to medical therapy for cryptogenic stroke: a meta-analysis of randomised controlled trials. Heart 2018, 104: a2. DOI: 10.1136/heartjnl-2018-bcs.2.Peer-Reviewed Original ResearchMedical therapyCryptogenic strokeDevice closureAtrial fibrillationRecurrent strokePFO closureNew-onset atrial fibrillationRisk of AFOnset atrial fibrillationPrimary safety endpointPrimary efficacy endpointPrevention of strokeEfficacy endpointFurther strokeSafety endpointTreat basisPatent foramenPatientsTherapyStrokePFOTrialsEndpointPreventionClosurePatent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials
Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, Demir O, Williams L, Iglesias JF, Sutaria N, Malik I, Davies J, Mayet J, Francis D, Sen S. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. European Heart Journal 2018, 39: 1638-1649. PMID: 29590333, PMCID: PMC5946888, DOI: 10.1093/eurheartj/ehy121.Peer-Reviewed Original ResearchConceptsMedical therapyCryptogenic strokeDevice closurePFO closureAtrial fibrillationRecurrent strokeLarge shuntPatent foramenNew-onset atrial fibrillationRisk of AFOnset atrial fibrillationPrimary safety endpointPrimary efficacy endpointAtrial septal aneurysmPrevention of strokeSignificant reductionEfficacy endpointFurther strokeSafety endpointTreat basisSeptal aneurysmSmall shuntPatientsTherapyStroke
2017
TCT-269 PFO Closure is Superior to Medical Therapy for Cryptogenic Stroke: a meta-analysis of randomised controlled trials
Ahmad Y, Shun-Shin M, Howard J, Cook C, Petraco R, Demir O, Mikhail G, Sutaria N, Baker C, Davies J, Mayet J, Francis D, Malik I, Sen S. TCT-269 PFO Closure is Superior to Medical Therapy for Cryptogenic Stroke: a meta-analysis of randomised controlled trials. Journal Of The American College Of Cardiology 2017, 70: b111. DOI: 10.1016/j.jacc.2017.09.346.Peer-Reviewed Original Research